1-7 of 7
M. Quinn
Close
Sort by
Journal Articles

Factor VIII trafficking to CD4 + T cells shapes its immunogenicity and requires several types of antigen-presenting cells

Radoslaw Kaczmarek, Annie R. Piñeros, Paige E. Patterson, Thais B. Bertolini, George Q. Perrin, Alexandra Sherman, Jameson Born, Sreevani Arisa, Matthew C. Arvin, Malgorzata M. Kamocka, Michelle M. Martinez, Kenneth W. Dunn, Sean M. Quinn, Johnathan J. Morris, Amelia R. Wilhelm, Tsuneyasu Kaisho, Maite Munoz-Melero, Moanaro Biswas, Mark H. Kaplan, Amelia K. Linnemann, Lindsey A. George, Rodney M. Camire, Roland W. Herzog
Journal: Blood
Blood (2023) 142 (3): 290–305.
https://doi.org/10.1182/blood.2022018937
Published: 2023
Includes: Multimedia, Supplemental data
Journal Articles

The Regulation of STAT3 and Its Role in the Adhesion and Migration of Chronic Lymphocytic Leukaemia Cells

Sarah Brophy, Fiona M Quinn, PhD, David O'Brien, FAMLs, Paul Browne, MD, Elisabeth A. Vandenberghe, MB, PhD, Anthony M. McElligott, PhD
Journal: Blood
Blood (2016) 128 (22): 4347.
https://doi.org/10.1182/blood.V128.22.4347.4347
Published: 2016
Journal Articles

Turning the Heat up a Notch in Biclonal Lymphoproliferative Disorders

Helen Fogarty, Anita Dowling, David O'Brien, Christopher Laurence Bacon, Patrick Thornton, Brian Hennessy, MD MRCPI, FRCPath, Hilary M O'Leary, FRCPath, Gerard Crotty, Robert Henderson, James Nolan, Elisabeth A. Vandenberghe, MB, MRCPI, MRCPath, PhD, Fiona M Quinn, PhD
Journal: Blood
Blood (2016) 128 (22): 5569.
https://doi.org/10.1182/blood.V128.22.5569.5569
Published: 2016
Journal Articles

Minimal Residual Disease (MRD) Status in FCR-Treated CLL Patients at the End of Treatment Influences Progression Free Survival (PFS), Results of the Ctrial-IE (ICORG) 07-01/ CLL Ireland Study, with Mutational Analysis Providing Additional Insight

Niamh Appleby, FRCPath, Fiona M Quinn, PhD, David O'Brien, FAMLs, Smyth Liam, MRCPI, Johanna Kelly, BSc, Imelda Parker, Kathleen Scott, PhD, Mary R Cahill, MB, FRCPath, Gerard Crotty, Helen Enright, MD FRCPI, FRCPath, Brian Hennessy, MD MRCPI, FRCPath, Andrew Hodgson, MBBS, BSc, FRCP, FRCPath, Maeve Leahy, FRCPath, Hilary M O'Leary, FRCPath, Michael E O'Dwyer, MD, Amjad Hayat, MBBS, MRCP, MRCPath, PhD, Elisabeth A. Vandenberghe, MB, MRCPI, MRCPath, PhD
Journal: Blood
Blood (2016) 128 (22): 3237.
https://doi.org/10.1182/blood.V128.22.3237.3237
Published: 2016
Journal Articles

Detection of Mutations in SF3B1 in Chronic Lymphocytic Leukaemia Patients By Reverse Transcription (Rt) Polymerase Chain Reaction and High Resolution Melt Curve Analysis, an Alternative Approach to Next Generation Sequencing for Routine Molecular Diagnostic Laboratories?

Fiona M Quinn, PhD, Deirdre Waldron, M.Sc., David O'Brien, FAMLs, Johanna Kelly, BSc, Kathleen Scott, PhD, Amjad Hayat, MBBS, MRCP, FRCPath, PhD, Elisabeth A. Vandenberghe, MB, PhD
Journal: Blood
Blood (2015) 126 (23): 5283.
https://doi.org/10.1182/blood.V126.23.5283.5283
Published: 2015
Journal Articles

Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury

Brief Report
Eimear M. Gleeson, María G. Dichiara, Agustina Salicio, Louise M. Quinn, Clive Drakeford, Shane E. Russell, Patrick T. Walsh, Josune Orbe, José Hermida, Owen P. Smith, James S. O’Donnell, Ramón Montes, Roger J. S. Preston
Journal: Blood
Blood (2015) 126 (7): 915–919.
https://doi.org/10.1182/blood-2015-03-632877
Published: 2015
Includes: Supplemental data
Journal Articles

Phase 1, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Intravenous Alvespimycin (KOS-1022) in Patients with Refractory Hematological Malignancies.

Jeffrey Lancet, MD, Maria R. Baer, MD, Ivana Gojo, MD, M. Burton, M. Quinn, S.M. Tighe, Kapil Bhalla, MD, K. Kersey, S. Wells, Z. Zhong, PhD, B. Sadler, Maher Albitar, MD, Robert Johnson, MD, PhD, Alison Hannah, MBBS
Journal: Blood
Blood (2006) 108 (11): 1961.
https://doi.org/10.1182/blood.V108.11.1961.1961
Published: 2006